Reported just now
JMP Securities upgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Market Perform to Market Outperform with a price target of $13.00.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.70 yesterday, with a 52 week range of $6.92-$17.42.
Do you have the full recommendation so we'll know what changed their minds?
Sentiment: Strong Buy
Wonder what dirty tricks Adam has up his sleaves now...